Related Experiment Videos
Blood coagulation profile in long-term hormone replacement therapy with mestranol
F Al-Azzawi1, D Smith, D Parkin
1Department of Obstetrics and Gynaecology, Stobhill General Hospital, Glasgow, U.K.
Maturitas
|June 1, 1989
Abstract:
The coagulation profile of oophorectomised women on long-term (15 yr) hormone replacement therapy with mestranol (30 micrograms/day) is compared to that of women on long-term placebo. Analysis of these data showed no significant difference in prothrombin time, partial thromboplastin time or in anti-thrombin III level in these groups.